Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 AND SODIUM CHLORIDE 0 9.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 AND SODIUM CHLORIDE 0 9.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride provides potassium ions essential for nerve impulse transmission, muscle contraction, and acid-base balance. Sodium chloride provides sodium ions, which are critical for maintaining extracellular fluid volume, osmotic pressure, and electrochemical gradients.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion. Potassium chloride 0.3% (3 g/L) and sodium chloride 0.9%: administer at a rate not exceeding 10 mmol/h (0.75 g/h) of potassium, maximum 200 mmol (15 g) per 24 hours. Dose adjusted based on serum potassium and clinical status.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Not applicable as potassium and sodium are endogenous ions; distribution and elimination are rapid and depend on renal function and total body stores.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Potassium: Approximately 90% renal excretion, 10% fecal. Sodium: Excreted renally, >90% under normal conditions.
Category C
Category A/B
Electrolyte
Electrolyte